Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Dt, Dicker"'
Publikováno v:
Europe PubMed Central
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis of transformed and cancer cells but not of most normal cells. Recent studies have revealed an unforeseen toxicity of TRAIL toward normal human hepatocyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::034a99f741355fef06a1d36dcedb720c
http://europepmc.org/abstract/med/11103780
http://europepmc.org/abstract/med/11103780
Autor:
Allen JE; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA.; Current affiliation: Oncoceutics, Inc., Hummelstown, PA, USA., Krigsfeld G; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA., Patel L; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA., Mayes PA; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA., Dicker DT; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA.; Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, 19111, PA, USA., Wu GS; Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA., El-Deiry WS; Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA. wafik.eldeiry@fccc.edu.; Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, 19111, PA, USA. wafik.eldeiry@fccc.edu.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Oct 18; Vol. 23 (1), pp. 233. Date of Electronic Publication: 2024 Oct 18.
Autor:
Lulla AR; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA.; Graduate Program in Molecular Medicine, Penn State College of Medicine Hershey, PA, USA., Zhou Y; Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA., Ralff MD; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA.; MD/PhD Program, The Lewis Katz School of Medicine, Temple University Philadelphia, PA, USA., Lev A; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and The Lifespan Health System Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University Providence, RI, USA.; Hematology-Oncology Division, Brown University and The Lifespan Cancer Institute Providence, RI, USA.; Legorreta Cancer Center at Brown University, The Warren Alpert Medical School, Brown University Providence, RI, USA.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2022 Jan 15; Vol. 12 (1), pp. 315-326. Date of Electronic Publication: 2022 Jan 15 (Print Publication: 2022).
Autor:
Ray JE; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Division of Gynecologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Ralff MD; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; MD/PhD Program, the Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Jhaveri A; Master of Science in Biotechnology Program, the Warren Alpert Medical School, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Zhou L; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; Cancer Center at Brown University, the Warren Alpert Medical School, Brown University, Providence, RI, USA., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Ross EA; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; Cancer Center at Brown University, the Warren Alpert Medical School, Brown University, Providence, RI, USA.; Brown University and the Lifespan Cancer Institute, Providence, RI, USA.
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2021 Dec 02; Vol. 22 (10-12), pp. 554-563. Date of Electronic Publication: 2021 Oct 25.
Autor:
Zhao S; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Pathobiology Graduate Program, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute, Providence, RI, USA., Zhou L; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, RI, USA., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute, Providence, RI, USA., Lev A; Fox Chase Cancer Center, Philadelphia, PA, USA., Zhang S; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute, Providence, RI, USA.; Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, RI, USA., Ross E; Fox Chase Cancer Center, Philadelphia, PA, USA., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, USA. wafik@brown.edu.; Pathobiology Graduate Program, Brown University, Providence, RI, USA. wafik@brown.edu.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA. wafik@brown.edu.; Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute, Providence, RI, USA. wafik@brown.edu.; Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, RI, USA. wafik@brown.edu.; Fox Chase Cancer Center, Philadelphia, PA, USA. wafik@brown.edu.; Hematology/Oncology Division, Lifespan Cancer Institute, Providence, RI, USA. wafik@brown.edu.
Publikováno v:
Scientific reports [Sci Rep] 2021 Oct 22; Vol. 11 (1), pp. 20871. Date of Electronic Publication: 2021 Oct 22.
Autor:
Allen JE; Oncoceutics, Inc., Philadelphia, PA, USA., Kline CLB; Fox Chase Cancer Center, Philadelphia, PA, USA., Prabhu VV; Oncoceutics, Inc., Philadelphia, PA, USA., Wagner J; Fox Chase Cancer Center, Philadelphia, PA, USA., Ishizawa J; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Madhukar N; Weill Cornell Medicine, New York, NY, USA., Lev A; Fox Chase Cancer Center, Philadelphia, PA, USA., Baumeister M; Fox Chase Cancer Center, Philadelphia, PA, USA., Zhou L; Fox Chase Cancer Center, Philadelphia, PA, USA., Lulla A; Fox Chase Cancer Center, Philadelphia, PA, USA., Stogniew M; Oncoceutics, Inc., Philadelphia, PA, USA., Schalop L; Oncoceutics, Inc., Philadelphia, PA, USA., Benes C; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kaufman HL; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Pottorf RS; Provid Pharmaceuticals, Monmouth Junction, NJ, USA., Nallaganchu BR; Provid Pharmaceuticals, Monmouth Junction, NJ, USA., Olson GL; Provid Pharmaceuticals, Monmouth Junction, NJ, USA., Al-Mulla F; Kuwait University Medical School, Kuwait., Duvic M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu GS; Karmanos Cancer Institute, Detroit, MI, USA., Dicker DT; Fox Chase Cancer Center, Philadelphia, PA, USA., Talekar MK; The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lim B; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Elemento O; Weill Cornell Medicine, New York, NY, USA., Oster W; Oncoceutics, Inc., Philadelphia, PA, USA., Bertino J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Flaherty K; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wang ML; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stein M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., El-Deiry WS; Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2021 Oct 12; Vol. 12 (21), pp. 2231. Date of Electronic Publication: 2021 Oct 12 (Print Publication: 2021).
Autor:
Hernandez Borrero L; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, United States.; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, United States.; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States., Santiago J; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States., Sanders J; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States.; Department of Pediatrics, The Warren Alpert Medical School, Brown University, Providence, United States., Tian X; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, United States.; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States., Ahsan N; COBRE Center for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, United States., Lev A; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States., Zhou L; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, United States.; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, United States.; The Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, United States.; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, United States.; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, United States.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, United States.; Hematology-Oncology Division, Department of Medicine, Rhode Island Hospital and Brown University, Providence, United States.
Publikováno v:
ELife [Elife] 2021 Jul 29; Vol. 10. Date of Electronic Publication: 2021 Jul 29.
Autor:
Tian X; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, RI, USA; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA; Department of Pathology and Laboratory Medicine, Brown University Alpert Medical School, Providence, RI, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Ahsan N; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA; COBRE Center for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, RI, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA., Lulla A; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Lev A; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Abbosh P; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, RI, USA; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA; Department of Pathology and Laboratory Medicine, Brown University Alpert Medical School, Providence, RI, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Zhang S; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, RI, USA; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA; Department of Pathology and Laboratory Medicine, Brown University Alpert Medical School, Providence, RI, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University, Providence, RI, USA; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA; Department of Pathology and Laboratory Medicine, Brown University Alpert Medical School, Providence, RI, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Hematology-Oncology Division, Department of Medicine, Rhode Island Hospital and Brown University, Providence, RI, USA. Electronic address: wafik@brown.edu.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2021 Mar; Vol. 23 (3), pp. 304-325. Date of Electronic Publication: 2021 Feb 11.
Autor:
Ralff MD; MD/PhD Program, The Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Jhaveri A; Master of Science in Biotechnology Program, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Ray JE; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Division of Gynecologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Zhou L; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Lev A; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Campbell KS; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Ross EA; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; Hematology-Oncology Division, Brown University and the Lifespan Cancer Institute, Providence, RI, USA.; Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
Publikováno v:
Oncotarget [Oncotarget] 2020 Oct 20; Vol. 11 (42), pp. 3753-3769. Date of Electronic Publication: 2020 Oct 20 (Print Publication: 2020).
Autor:
Lev A; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Lulla AR; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ross BC; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ralff MD; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Makhov PB; Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. wafik.eldeiry@fccc.edu.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2018 May; Vol. 16 (5), pp. 754-766. Date of Electronic Publication: 2018 Mar 27.